US equities
|
MU
$1,046.38
▼-3.83%
NVDA
$231.32
▼-2.59%
SNDK
$1,617.66
▼-4.42%
AMD
$620.39
▼-3.94%
INTC
$106.87
▼-5.53%
SPCX
$162.37
▼-3.12%
META
$719.43
▼-0.26%
PLTR
$197.61
▲+1.80%
MU
$1,046.38
▼-3.83%
NVDA
$231.32
▼-2.59%
SNDK
$1,617.66
▼-4.42%
AMD
$620.39
▼-3.94%
INTC
$106.87
▼-5.53%
SPCX
$162.37
▼-3.12%
META
$719.43
▼-0.26%
PLTR
$197.61
▲+1.80%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about William Collier
Recent news which mentions William Collier
Lab Notes: Arbutus begins human testing of potential hepatitis B cure
March 24, 2023
Tickers
INNO
Tags
William Collier
Stacie Shepherd
Inno
From
Business Journals
Lab Notes: FDA approves Incyte's vitiligo treatment; Neuronetics gets a 'big win'
July 22, 2022
Tickers
INNO
Tags
Zynerba Pharmaceuticals Inc/
Arbutus Biopharma Corporation
Medical Devices
From
Business Journals
Bucks County biopharm firm files lawsuit against Moderna over Covid-19 vaccine
February 28, 2022
Tags
Pharmaceuticals
Moderna Inc/
Arbutus Biopharma Corporation
From
Business Journals